Journal article icon

Journal article

Treatment policy change to dihydroartemisinin-piperaquine contributes to the reduction of adverse maternal and pregnancy outcomes

Abstract:

Background: In Papua, Indonesia, maternal malaria is prevalent, multidrug resistant and associated with adverse outcomes for mother and baby. In March 2006, anti-malarial policy was revised for the second and third trimester of pregnancy to dihydroartemisinin-piperaquine (DHP) for all species of malaria. This study presents the temporal analysis of adverse outcomes in pregnancy and early life following this policy change. Methods: From April 2004 to May 2010, a standardized questionnaire was ...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1186/s12936-015-0794-0

Authors


Expand authors...
More from this funder
Funding agency for:
Price, R
Publisher:
BioMed Central Publisher's website
Journal:
Malaria Journal Journal website
Volume:
14
Issue:
1
Article number:
272
Publication date:
2015-01-01
DOI:
EISSN:
1475-2875
Source identifiers:
535676
Keywords:
Pubs id:
pubs:535676
UUID:
uuid:85852427-27fd-45d4-a2b9-07f03d451958
Local pid:
pubs:535676
Deposit date:
2015-11-16

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP